ISPOR 13th Annual European Congress
November 06, 2010 – November 09, 2010Prague, Czech Republic - Prague Congress Centre
November 8, 8:00 - 19:00
POSTER SESSION II: TRENDS IN COST EFFECTIVENESS STUDIES OF HIGH BUDGET IMPACT DRUGS
Saurabh Aggarwal, Senior Consultant
November 9, 8:00-16:00
POSTER SESSION III: THE USE OF HEALTH ECONOMICS TERMINOLOGY IN CLINICAL PUBLICATIONS: BRIDGING THE GAP FROM CLINICAL EFFECTIVENESS TO COMPARATIVE EFFECTIVENESS
Shelley Reich, Director, Customer Strategy, Medical Communications
November 9, 8:30-9:30
COMPARISONS OF FDA AND EMEA RISK MANAGEMENT REQUIREMENTS FOR RECENTLY APPROVED PRODUCTS
Yvonne Lis, Director, Health Outcomes
November 9, 16:00-17:00
W22: METHODOLOGICAL ISSUES IN THE ASSESSMENT OF COMORBIDITY INFLUENCE IN HEALTH OUTCOMES STUDIES
Victor A. Kiri, PhD, MSc, Director, Pharmacoepidemiology
Visit PAREXEL in the exhibit hall at stands 38 & 39.
Event Website >PAREXEL Speakers Bureau
PAREXEL is your reliable source for knowledgeable speakers on issues affecting the pharmaceutical, biological, and medical device industries.
In addition to being leading subject matter experts, members of the PAREXEL team are experienced at delivering lively and compelling presentations to a broad range of audiences. If you need a speaker for an upcoming event, please click here.